Lebok P, Bonte H, Kluth M, Moller-Koop C, Witzel I, Wolber L
Breast Cancer. 2021; 29(2):216-223.
PMID: 34625909
PMC: 8885507.
DOI: 10.1007/s12282-021-01301-5.
Takeda T, Komatsu M, Chiwaki F, Komatsuzaki R, Nakamura K, Tsuji K
Cell Death Dis. 2019; 10(12):876.
PMID: 31748500
PMC: 6868013.
DOI: 10.1038/s41419-019-2117-9.
Kim J, Ha G, Campo L, Denning M, Patel T, Osipo C
Oncotarget. 2017; 8(49):86799-86815.
PMID: 29156836
PMC: 5689726.
DOI: 10.18632/oncotarget.5717.
Bagu E, Miah S, Dai C, Spriggs T, Ogunbolude Y, Beaton E
Oncotarget. 2017; 8(7):11442-11459.
PMID: 28077797
PMC: 5355277.
DOI: 10.18632/oncotarget.14546.
Li M, Wen Y, Fu W
Cancer Inform. 2015; 13(Suppl 4):95-103.
PMID: 26279618
PMC: 4519351.
DOI: 10.4137/CIN.S15203.
SOD2 targeted gene editing by CRISPR/Cas9 yields Human cells devoid of MnSOD.
Cramer-Morales K, Heer C, Mapuskar K, Domann F
Free Radic Biol Med. 2015; 89:379-86.
PMID: 26208779
PMC: 4890619.
DOI: 10.1016/j.freeradbiomed.2015.07.017.
Manganese superoxide dismutase and breast cancer recurrence: a Danish clinical registry-based case-control study, and a meta-analysis.
Cronin-Fenton D, Christensen M, Lash T, Ahern T, Pedersen L, Garne J
PLoS One. 2014; 9(1):e87450.
PMID: 24498107
PMC: 3909115.
DOI: 10.1371/journal.pone.0087450.
Nongenomic Mechanisms of PTEN Regulation.
Fata J, Debnath S, Jenkins Jr E, Fournier M
Int J Cell Biol. 2012; 2012:379685.
PMID: 22536248
PMC: 3320059.
DOI: 10.1155/2012/379685.
Parkin gene alterations in ovarian carcinoma from northern Indian population.
Mehdi S, Ali A, Rizvi M
Pathol Oncol Res. 2011; 17(3):579-86.
PMID: 21221875
DOI: 10.1007/s12253-010-9351-x.
Undetectable and Decreased Expression of KIAA1949 (Phostensin) Encoded on Chromosome 6p21.33 in Human Breast Cancers Revealed by Transcriptome Analysis.
Su Y, Yang J, Tao L, Nguyen H, He P
J Cancer. 2010; 1:38-50.
PMID: 20842223
PMC: 2931353.
DOI: 10.7150/jca.1.38.
Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.
Mehdi S, Alam M, Batra S, Rizvi M
Med Oncol. 2010; 28(4):1520-6.
PMID: 20652448
DOI: 10.1007/s12032-010-9633-x.
Implication of snoRNA U50 in human breast cancer.
Dong X, Guo P, Boyd J, Sun X, Li Q, Zhou W
J Genet Genomics. 2009; 36(8):447-54.
PMID: 19683667
PMC: 2854654.
DOI: 10.1016/S1673-8527(08)60134-4.
RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK.
Brauer P, Tyner A
Cell Cycle. 2009; 8(17):2728-32.
PMID: 19652529
PMC: 3005195.
DOI: 10.4161/cc.8.17.9389.
Rak functions as a tumor suppressor by regulating PTEN protein stability and function.
Yim E, Peng G, Dai H, Hu R, Li K, Lu Y
Cancer Cell. 2009; 15(4):304-14.
PMID: 19345329
PMC: 2673492.
DOI: 10.1016/j.ccr.2009.02.012.
Loss of imprinting of IGF2 and H19, loss of heterozygosity of IGF2R and CTCF, and Helicobacter pylori infection in laryngeal squamous cell carcinoma.
Grbesa I, Marinkovic M, Ivkic M, Kruslin B, Novak-Kujundzic R, Pegan B
J Mol Med (Berl). 2008; 86(9):1057-66.
PMID: 18604514
DOI: 10.1007/s00109-008-0369-4.
Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey.
Tug E, Tug T, Elyas H, Coskunsel M, Emri S
J Carcinog. 2006; 5:23.
PMID: 16925806
PMC: 1559681.
DOI: 10.1186/1477-3163-5-23.
Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27.
Cesari R, Martin E, Calin G, Pentimalli F, Bichi R, McAdams H
Proc Natl Acad Sci U S A. 2003; 100(10):5956-61.
PMID: 12719539
PMC: 156308.
DOI: 10.1073/pnas.0931262100.
Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.
Campbell M, Wollish W, Lobo M, Esserman L
In Vitro Cell Dev Biol Anim. 2003; 38(6):326-33.
PMID: 12513120
DOI: 10.1290/1071-2690(2002)038<0326:EAFCLD>2.0.CO;2.
Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak.
Chandrasekharan S, Qiu T, Alkharouf N, Brantley K, Mitchell J, Liu E
Mol Cell Biol. 2002; 22(14):5235-47.
PMID: 12077350
PMC: 139782.
DOI: 10.1128/MCB.22.14.5235-5247.2002.
Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3.
Utada Y, Haga S, Kajiwara T, Kasumi F, Sakamoto G, Nakamura Y
Jpn J Cancer Res. 2000; 91(3):293-300.
PMID: 10760688
PMC: 5926368.
DOI: 10.1111/j.1349-7006.2000.tb00944.x.